|
|
|
|
|
|
Notes |
Dec. 31, 2019 |
|
Dec. 31, 2018 |
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Net profit for the period |
|
11,803,555 |
|
9,555,755 |
Other comprehensive income items that will not be reclassified to the Profit or Loss: |
|
|
|
|
Net change in fair value of debt instruments measured at fair value through other comprehensive income |
|
212,967 |
|
57,026 |
Other comprehensive income items that is or may be reclassified to the profit or loss: |
|
|
|
|
Net change in fair value of debt instruments measured at fair value through other comprehensive income |
|
5,944,586 |
|
(2,164,847) |
Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income |
|
(184,921) |
|
- |
Total other comprehensive income for the year |
|
17,776,187 |
|
7,447,934 |
|
|
|
|
|
|
|
|
|
|
Separate cash flow for the period ended December 31, 2019 |
|
Notes |
Dec. 31, 2019 |
|
Dec. 31, 2018 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
Profit before income tax |
|
16,537,441 |
|
13,052,594 |
Adjustments to reconcile net profit to net cash provided by operating activities |
|
|
|
|
Fixed assets depreciation |
24 |
576,544 |
|
390,830 |
Impairment charge for credit losses (Loans and advances to customers) |
12 |
1,610,878 |
|
3,076,023 |
Other provisions charges |
29 |
461,869 |
|
101,501 |
Impairment charge for credit losses (due from banks) |
12 |
9,503 |
|
- |
Impairment charge for credit losses (financial investments) |
12 |
(184,921) |
|
- |
Impairment charge for other assets |
23 |
(93,313) |
|
316,763 |
Exchange revaluation differences for financial assets at fair value through OCI |
20 |
1,593,030 |
|
(102,991) |
Intangible assets amortization |
|
238,715 |
|
130,208 |
Impairment charge financial assets at fair value through OCI |
21 |
- |
|
39,561 |
Exchange differences in financial investments in subsidiary |
22 |
4,680 |
|
(465) |
Utilization of other provisions |
29 |
(28,135) |
|
(2,114) |
Other provisions no longer used |
29 |
(6,910) |
|
(17,670) |
Exchange differences of other provisions |
29 |
(110,062) |
|
(2,269) |
(Profits) losses from selling property, plant and equipment |
11 |
(1,439) |
|
(1,045) |
(Profits) losses from selling financial investments |
21 |
(497,894) |
|
(441,628) |
Shares based payments |
|
464,539 |
|
408,346 |
Operating profits before changes in operating assets and liabilities |
|
20,574,525 |
|
16,947,644 |
|
|
|
|
|
Net decrease (increase) in assets and liabilities |
|
|
|
|
Due from banks |
15 |
(8,870,547) |
|
(13,661,577) |
Treasury bills and other governmental notes |
41 |
- |
|
4,640,524 |
Financial assets at fair value through P&L |
21 |
2,318,924 |
|
4,557,492 |
Derivative financial instruments |
20 |
(2,910) |
|
(66,141) |
Loans and advances to banks and customers |
18 - 19 |
(14,533,328) |
|
(21,255,952) |
Other assets |
42 |
162,502 |
|
(2,263,465) |
Due to banks |
25 |
4,550,788 |
|
5,381,901 |
Due to customers |
26 |
19,143,183 |
|
34,573,102 |
Income tax obligations paid |
|
(3,625,579) |
|
(2,778,973) |
Other liabilities |
28 |
1,894,934 |
|
1,025,022 |
Net cash provided from operating activities |
|
21,612,492 |
|
27,099,577 |
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
Payment for purchases of subsidiary and associates |
|
- |
|
(10,575) |
Payment for purchases of property, plant, equipment and branches constructions |
|
(1,301,415) |
|
(874,708) |
Proceeds from selling property, plant and equipment |
11 |
1,439 |
|
1,045 |
Proceeds from redemption of financial assets at amortized cost |
21 |
43,937,957 |
|
5,532,271 |
Payment for purchases of financial assets at amortized cost |
21 |
(76,516,842) |
|
(33,995,313) |
Payment for purchases of financial assets at fair value through OCI |
21 |
(50,954,311) |
|
(12,670,761) |
Proceeds from selling financial assets at fair value through OCI |
|
54,855,966 |
|
2,059,341 |
Net cash used in investing activities |
|
(29,977,206) |
|
(39,958,700) |
|
|
|
|
|
Cash flow from financing activities |
|
|
Increase (decrease) in long term loans |
27 |
(448,783) |
46,793 |
Dividend paid |
|
(2,700,544) |
(2,143,177) |
Capital increase |
|
105,413 |
50,315 |
Net cash used in (provided from) financing activities |
|
(3,043,914) |
(2,046,069) |
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalent during the year |
|
(11,408,628) |
(14,905,192) |
Beginning balance of cash and cash equivalent |
|
34,303,645 |
49,208,837 |
Cash and cash equivalent at the end of the year |
|
22,895,017 |
34,303,645 |
|
|
|
|
|
|
|
Cash and cash equivalent comprise: |
|
|
Cash and balances with central bank |
15 |
28,273,962 |
20,058,974 |
Due from banks |
16 |
28,370,183 |
46,518,892 |
Treasury bills and other governmental notes |
17 |
27,634,062 |
41,999,252 |
Obligatory reserve balance with CBE |
15 |
(22,397,310) |
(13,526,763) |
Due from banks with maturities more than three months |
|
(10,593,903) |
(10,733,386) |
Treasury bills with maturity more than three months |
|
(28,391,977) |
(50,013,324) |
Total cash and cash equivalent |
|
22,895,017 |
34,303,645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|